NKMAX Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Sangwoo Park

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	0.006%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	sin datos

Actualizaciones recientes de la dirección

Recent updates

Introducing NKMAX (KOSDAQ:182400), A Stock That Climbed 96% In The Last Year

Feb 10

CEO

Sangwoo Park (54 yo)

no data

Permanencia

Mr. Sangwoo Park was Executive Chairman of the Board at NKGen Biotech, Inc. since September 2023 until March 14, 2024. Mr. Park is Founder and was Executive Chairman of Legacy NKGen from May 2019 to Septem...

NKMAX Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

No independent directors

No independent directors

Recent updates

New major risk - Share price stability

NKMAX CO., Ltd. announced that it has received KRW 7.5 billion in funding

NKMAX CO., Ltd. announced that it has received KRW 8.5 billion in funding

New minor risk - Shareholder dilution

Full year 2022 earnings released: ₩1,359 loss per share (vs ₩1,420 loss in FY 2021)

No independent directors

No independent directors

NKMAX CO., Ltd. announced that it has received KRW 21.40019775 billion in funding

NKMAX CO., Ltd. announced that it expects to receive KRW 7.00019775 billion in funding

Introducing NKMAX (KOSDAQ:182400), A Stock That Climbed 96% In The Last Year

New 90-day high: ₩20,900

New 90-day high: ₩18,000

NKMAX CO., Ltd. announced that it has received KRW 29.9999702 billion in funding from a group of investors

New 90-day low: ₩12,900

New 90-day low: ₩12,950

New 90-day high - ₩15,800

CEO

Permanencia